Twitter Beğeni Hilesi

a fantastic resource....really excited to support this work through CARD at the NIH IRP. Next comes the exciting part...

gp2.org/the-components… Aligning Science Across Parkinson’s says GP2 release 3 is now official. Shout outs to the team for sharing > 14K samples! Nice work in particular from Hampton Leonard Kristin Levine Mary Makarious #DanV and #MatK on the blog post and README. READMEs, always important 🧐.

It’s quafftide somewhere. Here in fact.

A nice thread here:

📢 Apply to get trained in data science while working with a ton of talented and motivated scientists on Alzheimer’s and related dementias research at #CARD ! 📢 🤩

V Excited about this....Mis-spliced transcripts generate de novo proteins in TDP-43-related ALS/FTD biorxiv.org/content/10.110…

If you are a doctor or scientist based in Africa, Asia or Latin America interested in getting a master's in clinical neurology or data science via distance learning UCL or UMBC, apply for GP2 support! Learn more: gp2.org/opportunities/…

🎉In case you missed it📢 BLAAC-PD is expanding to six sites, allowing the initiative to continue to grow its partnerships with traditionally underrepresented populations and helping to unlock the genetic architecture of #ParkinsonsDisease. michaeljfox.org/publication/st…

I wrote a blog post for International Women's Day, featuring women in #datascience and #neuroscience at The National Institute on Aging (NIA)'s Center for #Alzheimers and related dementias! card.nih.gov/news-events/ca… #scicomm #InternationalWomensDay

Great presentation of mcornejo in #IIIcongressobrasileironeurogenetica LARGE-PD Aligning Science Across Parkinson’s Artur Schumacher-Schuh Nacho Mata

Funding opportunity! GP2 is co-funding two places for MDS Aspen Course. If you are an early career Movement Disorders Fellow who identifies as belonging to an underrepresented group in #PD research, we encourage you to apply. Deadline is 5/1: pulse.ly/4uqz6ymutl

New preprint from the team at CARD, nominating novel drug targets for neurodegenerative disease using multi-omic and genetic data. Hoping this is a starting point for community target discovery specifically focused on ADRD. medrxiv.org/content/10.110…

41 novel targets, network insights and potential tox inferences ... #opensource #openscience ... app here …ard-ndd-smr-home-syboky.streamlit.app. Awesome work from Chelsea X. A. (sensibly twitter averse) to leverage public resource to do this (thx Open Targets and other for the APIs)!

Pssst, next GP2 release in ~2 weeks 🤐. Release 5 for Cinco de Mayo (well a few days after).

Dramatic improvement for Oxford Nanopore DRS using kits RNA004 vs RNA002 Northeastern University Bioengineering a) Human poly-A RNA alignment identity: 2019 (RNA002, 86%), 2022 (RNA002, 89.8%), 2023 (RNA004, 95.6%) b) Human MT poly-A RNA read alignments (2019 vs 2023). Colored lines = base mismatches Mark Akeson 🇺🇸🇺🇦

We also have some new WGS data from the Monogenic Disease Network in this release! Check out the blog post for more info 🧬 gp2.org/the-components…

Been a great day for publications from the team. Mathew Koretsky and the team great job on showing genetic overlap and in some instances a depletion of genetic risk across and within neurodegenerative diseases.

love this collaboration!

Kimberley has done an amazing job standing up high throughput long read sequencing at CARD….

Great opportunity!!! INTERNEURONA could you share it between your #LATAM colleagues???